Gilead, the pharmaceutical company that makes the drug remdesivir - the only drug approved in the United States so far to treat COVID-19 - says it will be able to meet global demand for the antiviral in October after increasing its production capacity. LEE : Good news in the fight against coronavirus: possible treatments, vaccines and findings
Gilead increases remdesivir production capacity
2020-08-07T20:25:37.914Z
Gilead, the pharmaceutical company that makes the drug remdesivir - the only drug approved in the United States so far to treat covid-19 - says it will be able to meet global demand for the antivi ...